230 related articles for article (PubMed ID: 22456625)
41. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.
Huang W; Paul D; Calin GA; Bayraktar R
Cells; 2023 Dec; 13(1):. PubMed ID: 38201290
[TBL] [Abstract][Full Text] [Related]
42. miR-223: infection, inflammation and cancer.
Haneklaus M; Gerlic M; O'Neill LA; Masters SL
J Intern Med; 2013 Sep; 274(3):215-26. PubMed ID: 23772809
[TBL] [Abstract][Full Text] [Related]
43. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer.
Labbaye C; Testa U
J Hematol Oncol; 2012 Mar; 5():13. PubMed ID: 22453030
[TBL] [Abstract][Full Text] [Related]
44. HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis.
Bagger FO; Rapin N; Theilgaard-Mönch K; Kaczkowski B; Jendholm J; Winther O; Porse B
Blood; 2012 Jun; 119(26):6394-5. PubMed ID: 22745298
[No Abstract] [Full Text] [Related]
45. RNA-binding proteins in hematopoiesis and hematological malignancy.
Hodson DJ; Screen M; Turner M
Blood; 2019 May; 133(22):2365-2373. PubMed ID: 30967369
[TBL] [Abstract][Full Text] [Related]
46. Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.
Goyama S; Kitamura T
Cancer Sci; 2017 Apr; 108(4):553-562. PubMed ID: 28100030
[TBL] [Abstract][Full Text] [Related]
47. Celebrating 25 Years of MicroRNA Research: From Discovery to Clinical Application.
Sempere LF
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018550
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine.
Bonifer C; Bowen DT
Expert Rev Mol Med; 2010 Feb; 12():e6. PubMed ID: 20152067
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune.
Fatica A; Fazi F
Int J Mol Sci; 2013 Oct; 14(10):20930-53. PubMed ID: 24145746
[TBL] [Abstract][Full Text] [Related]
50. Guest editorial: Epigenetics of hematopoiesis and hematological malignancies.
Iwama A
Int J Hematol; 2012 Oct; 96(4):403-4. PubMed ID: 23015418
[No Abstract] [Full Text] [Related]
51. X-chromosome-encoded microRNA-19 and -18 are possible modulators of female immunity.
Gantier MP
Bioessays; 2013 Aug; 35(8):671. PubMed ID: 23625822
[No Abstract] [Full Text] [Related]
52. The impact of Mir-9 regulation in normal and malignant hematopoiesis.
Khosravi A; Alizadeh S; Jalili A; Shirzad R; Saki N
Oncol Rev; 2018 Jan; 12(1):348. PubMed ID: 29774136
[TBL] [Abstract][Full Text] [Related]
53. MiR-125 Family in Cardiovascular and Cerebrovascular Diseases.
Wang Y; Tan J; Wang L; Pei G; Cheng H; Zhang Q; Wang S; He C; Fu C; Wei Q
Front Cell Dev Biol; 2021; 9():799049. PubMed ID: 34926475
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of miR-21 as a novel approach for leukemia therapy.
Feng Y; Chen X; Gao L
J Formos Med Assoc; 2010 Sep; 109(9):621-3. PubMed ID: 20879171
[No Abstract] [Full Text] [Related]
55. Probing the complexity of miRNA expression across hematopoiesis.
Petriv OI; Hansen CL; Humphries RK; Kuchenbauer F
Cell Cycle; 2011 Jan; 10(1):2-3. PubMed ID: 21191177
[No Abstract] [Full Text] [Related]
56. MicroRNA-155 and Its Role in Malignant Hematopoiesis.
Ranganath P
Biomark Insights; 2015; 10():95-102. PubMed ID: 26523117
[TBL] [Abstract][Full Text] [Related]
57. [On the problem of the classification and terminology of tumors of the hematopoetic organs].
LASIENE J; JANKEVICIUTE J; STALIORAITYTE E; LIUTKUS L
Sveikatos Apsauga; 1961 Sep; 6():15-9. PubMed ID: 14462595
[No Abstract] [Full Text] [Related]
58. miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.
Lechman ER; Gentner B; Ng SWK; Schoof EM; van Galen P; Kennedy JA; Nucera S; Ciceri F; Kaufmann KB; Takayama N; Dobson SM; Trotman-Grant A; Krivdova G; Elzinga J; Mitchell A; Nilsson B; Hermans KG; Eppert K; Marke R; Isserlin R; Voisin V; Bader GD; Zandstra PW; Golub TR; Ebert BL; Lu J; Minden M; Wang JCY; Naldini L; Dick JE
Cancer Cell; 2016 Apr; 29(4):602-606. PubMed ID: 27070706
[No Abstract] [Full Text] [Related]
59. [Therapy of malignant diseases of the hematopoietic system].
HEILMEYER L; OBRECHT P
Strahlentherapie; 1959; Suppl 43():213-22. PubMed ID: 14400652
[No Abstract] [Full Text] [Related]
60. Divergent roles of
Elias HK; Khalaj M; Park CY
Transl Cancer Res; 2016 Aug; 5(Suppl 2):S328-S331. PubMed ID: 33088733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
